Epithelial Stem Cell Culture Medium for Long-Term Organoid Expansion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing culture media for epithelial stem cells are inefficient in promoting long-term culture and organoid formation, necessitating improved methods for expanding these cells and maintaining their stem or progenitor cell phenotype.

Innovation Solution

A culture medium comprising an ErbB3/4 ligand, one or more FGFR2b ligands, and a BMP inhibitor, which induces heterodimerization of ErbB3 or ErbB4 with ErbB2, elicits tyrosine phosphorylation of FRS2α or FRS2β, and neutralizes BMP activity, enhancing cell culture efficiency and organoid formation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional culture media are used for epithelial stem cells, then basic cell maintenance is achieved, but organoid formation efficiency is low and long-term culture is difficult

Engineering Contradiction:
Improveorganoid formation efficiencyVSAvoidlong-term culture stability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The culture medium composition is modified by adding specific growth factors (ErbB3/4 ligand, FGFR2b ligand, BMP inhibitor) to change the biochemical parameters of the culture environment, thereby improving organoid formation efficiency and long-term culture stability

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The culture medium is formulated as a composite system containing multiple growth factors and inhibitors working synergistically (ErbB3/4 ligand for heterodimerization, FGFR2b ligand for tyrosine phosphorylation, BMP inhibitor for activity neutralization) to achieve both high organoid formation efficiency and stable long-term culture

Inventive Principle:
Principle #40Composite materials

2Quantity of substance

If starting material is limited, then cell population expansion is constrained, but sufficient cells are needed for applications like drug screening

Engineering Contradiction:
Improvecell population sizeVSAvoidexpansion efficiency
Core Design Contradiction:
Quantity of substanceVSProductivity

Solution Approach 1:

The culture medium is prepared in advance with optimized concentrations of ErbB3/4 ligand, FGFR2b ligand, and BMP inhibitor to create optimal conditions from the start, enabling maximum expansion efficiency even with limited starting material

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

Specific biochemical parameters of the culture medium (growth factor concentrations, inhibitor levels) are adjusted to enhance cell proliferation and organoid formation, allowing efficient expansion of cell populations from limited starting material

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The medium allows for extended cell passage and increased organoid formation, providing a larger cell population for applications like drug screening and cell-based therapies, particularly useful with limited starting material.

Implementation Method 1

the ErbB3/4 ligand induces the heterodimerization of ErbB3 or ErbB4 with ErbB2

Methodology Applied
Scientific EffectHeterodimerization:

Implementation Method 2

the FGFR2b ligand elicits tyrosine phosphorylation of FRS2α or FRS2β

Methodology Applied
Scientific EffectTyrosine phosphorylation:

Implementation Method 3

the BMP inhibitor binds to a BMP molecule to form a complex wherein the BMP activity is neutralized

Methodology Applied
Scientific EffectMolecular binding and complex formation:

Data Source

PatentEP3224346B1Culture medium
Publication Date: 2026.04.22 KONINK NEDERLANDSE AKADE VAN WETENSCHAPPEN
  • EP3224346B1 patent drawingFigure 1A~1B
  • EP3224346B1 patent drawingFigure 2A~2B
  • EP3224346B1 patent drawingFigure 3A

AI summary

The invention relates to improved culture methods for expanding epithelial stem cells and obtaining organoids, to culture media involved in said methods,and to uses of said organoids.